Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06871969

Clinical Evaluation of Pre-hospital Stroke Triage Devices - Electroencephalography

Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2025-10-03

275

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating a portable EEG-based triage device called StrokePointer to detect large vessel occlusion (LVO) strokes in patients suspected of acute stroke in the pre-hospital setting. The study aims to validate the safety and effectiveness of StrokePointer, which could help ambulance personnel identify LVO strokes early and reduce delays in transferring patients to specialized hospitals capable of performing endovascular thrombectomy (EVT). Each participant will undergo a single dry electrode EEG measurement using the StrokePointer headset, which records brain activity for about two minutes. The device includes a headset, portable suitcase with a mobile computing device and EEG amplifier, and software for data acquisition and analysis. The study is a prospective, multi-center cohort design focused on adult patients with suspected stroke symptoms starting less than 24 hours prior. Participants will have EEG data collected and analyzed to assess data quality and diagnostic accuracy for LVO stroke detection. Clinical and radiological information will also be gathered. Researchers will monitor safety by tracking adverse device-related events and skin reactions. The study will evaluate usability based on ambulance personnel feedback. The total involvement includes the EEG procedure performed in the ambulance before hospital arrival, with outcomes measured within 24 hours of symptom onset.

CONDITIONS

Brief Title

Clinical Evaluation of EEG Device for the Triage of Stroke Patients in the Ambulance

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Suspected acute stroke as judged by ambulance personnel
  • Age 18 years or older
  • Onset of symptoms or last seen well less than 24 hours ago
  • Written informed consent by patient or legal representative (deferred)
Not Eligible

You will not qualify if you...

  • Injuries or infections of the scalp where the EEG headset would be placed

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - Up to 24 hours

Participants are screened for eligibility to participate in the trial.

1 visit (in-person during ambulance transport)

Diagnostic Evaluation

Duration - Approximately 2 minutes

Participants undergo a single dry electrode EEG measurement with the StrokePointer device to collect EEG data for stroke triage.

1 visit (in-person during ambulance transport)

Trial Site Locations

Total: 1 location

1

Amsterdam University Medical Centers, location AMC

Amsterdam, North Holland, Netherlands, 1105AZ

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

Multifactorial Risk Stratification in Acute and Chronic Card...

Cardiovascular Diseases

Actively Recruiting

2 locations

Beneficial Effects of Perfect Heartio Drink in Improving Car...

Cardiovascular Diseases

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here